Heparin-binding EGF-like Growth Factor Induces Heart Interstitial Fibrosis Via an Akt/mTor/p70s6k Pathway

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Sep 18

PMID 22984591

Citations 30

Authors

Hong Lian

Yuanwu Ma

Juan Feng

Wei Dong

Qing Yang

Dan Lu

Lianfeng Zhang

Affiliations

Soon will be listed here.

Abstract

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is essential for maintaining normal function of the adult heart and is known to play an important role in myocardial remodeling. In the present study, we observed that heart-specific HB-EGF transgenic (TG) mice had systolic dysfunction with decreased fractional shortening (FS%), increased end-systolic diameter (LVIDs) at 5 months of age, increased heart fibrosis, and increased mRNA expression of Col1α1 and Col3α1 at 1, 3, 5 and 7 months of age compared to nontransgenic (NTG) littermates. However, the left ventricular anterior wall thickness at end-systole (LVAWs) of the TG mice was not different than the NTG mice. Phosphorylation levels of Akt, mTor and p70s6k were increased due to HB-EGF expression in TG mice compared with the NTG mice at 3 and 7 months of age. Additionally, activated Akt, mTor and p70s6k were co-localized with vimentin to cardiac fibroblasts isolated from TG mice. Furthermore, HB-EGF significantly increased phosphorylation levels of Akt, mTor and p70s6k and increased expression of type I collagen in cultured primary cardiac fibroblasts. Rapamycin (Rapa) and CRM197, inhibitors of mTor and HB-EGF respectively, could inhibit the expression of type I collagen in the cultured primary cardiac fibroblasts and Rapa suppressed interstitial fibrosis of the heart tissues in vivo. In addition, a BrdU assay showed that HB-EGF increased proliferation of cardiac fibroblasts by 30% compared with cells without HB-EGF treatment. HB-EGF-induced proliferation was completely diminished in the presence of Rapa. These results suggest that HB-EGF induced heart fibrosis and proliferation of cardiac fibroblasts occurs through activation of the Akt/mTor/p70s6k pathway.

Citing Articles

Unraveling the heart-brain axis: shared genetic mechanisms in cardiovascular diseases and Schizophrenia.

Shen J, Jiang C Schizophrenia (Heidelb). 2024; 10(1):113.

PMID: 39609470 PMC: 11605010. DOI: 10.1038/s41537-024-00533-6.

HB-EGF Plasmatic Level Contributes to the Development of Early Risk Prediction Nomogram for Severe COVID-19 Cases.

Moatar A, Chis A, Nitusca D, Oancea C, Marian C, Sirbu I Biomedicines. 2024; 12(2).

PMID: 38397975 PMC: 10886796. DOI: 10.3390/biomedicines12020373.

DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts.

Shumliakivska M, Luxan G, Hemmerling I, Scheller M, Li X, Muller-Tidow C Nat Commun. 2024; 15(1):606.

PMID: 38242884 PMC: 10799021. DOI: 10.1038/s41467-023-43003-w.

Inhibition of the mTORC1 pathway alleviates adipose tissue fibrosis.

Gong S, Li C, Leng Q, Liu C, Zhu Y, Zhang H Heliyon. 2023; 9(11):e21526.

PMID: 38034664 PMC: 10681937. DOI: 10.1016/j.heliyon.2023.e21526.

Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit.

Samidurai A, Saravanan M, Ockaili R, Kraskauskas D, Lau S, Kodali V Int J Mol Sci. 2023; 24(10).

PMID: 37240345 PMC: 10218967. DOI: 10.3390/ijms24108998.

References

Bridle K, Li L, ONeill R, Britton R, Bacon B . Coordinate activation of intracellular signaling pathways by insulin-like growth factor-1 and platelet-derived growth factor in rat hepatic stellate cells. J Lab Clin Med. 2006; 147(5):234-41. DOI: 10.1016/j.lab.2005.12.009. View

Shirakata Y, Kimura R, Nanba D, Iwamoto R, Tokumaru S, Morimoto C . Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci. 2005; 118(Pt 11):2363-70. DOI: 10.1242/jcs.02346. View

Juan F, Wei D, Xiongzhi Q, Ran D, Chunmei M, Lan H . The changes of the cardiac structure and function in cTnTR141W transgenic mice. Int J Cardiol. 2008; 128(1):83-90. DOI: 10.1016/j.ijcard.2008.03.006. View

Higashiyama S, Lau K, Besner G, Abraham J, Klagsbrun M . Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem. 1992; 267(9):6205-12. View

Higashiyama S, Iwabuki H, Morimoto C, Hieda M, Inoue H, Matsushita N . Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci. 2008; 99(2):214-20. PMC: 11158050. DOI: 10.1111/j.1349-7006.2007.00676.x. View

Das S, Wang X, Paria B, Damm D, Abraham J, Klagsbrun M . Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development. 1994; 120(5):1071-83. DOI: 10.1242/dev.120.5.1071. View

Reynolds C, Eguchi S, Frank G, Motley E . Signaling mechanisms of heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells. Hypertension. 2002; 39(2 Pt 2):525-9. DOI: 10.1161/hy0202.103076. View

Raab G, Klagsbrun M . Heparin-binding EGF-like growth factor. Biochim Biophys Acta. 1998; 1333(3):F179-99. DOI: 10.1016/s0304-419x(97)00024-3. View

Kiso S, Kawata S, Tamura S, Inui Y, Yoshida Y, Sawai Y . Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. Gastroenterology. 2003; 124(3):701-7. DOI: 10.1053/gast.2003.50097. View

10.

Iwamoto R, Yamazaki S, Asakura M, Takashima S, Hasuwa H, Miyado K . Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci U S A. 2003; 100(6):3221-6. PMC: 152273. DOI: 10.1073/pnas.0537588100. View

11.

Zhu J, Wu J, Frizell E, Liu S, Bashey R, Rubin R . Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology. 1999; 117(5):1198-204. DOI: 10.1016/s0016-5085(99)70406-3. View

12.

Miyagawa J, Higashiyama S, Kawata S, Inui Y, Tamura S, Yamamoto K . Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J Clin Invest. 1995; 95(1):404-11. PMC: 295446. DOI: 10.1172/JCI117669. View

13.

Means A, Ray K, Singh A, Washington M, Whitehead R, Harris Jr R . Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. Gastroenterology. 2003; 124(4):1020-36. DOI: 10.1053/gast.2003.50150. View

14.

Lemjabbar H, Basbaum C . Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat Med. 2002; 8(1):41-6. DOI: 10.1038/nm0102-41. View

15.

Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T . Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med. 2002; 8(1):35-40. DOI: 10.1038/nm0102-35. View

16.

Abraham J, Damm D, BAJARDI A, Miller J, Klagsbrun M, Ezekowitz R . Heparin-binding EGF-like growth factor: characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochem Biophys Res Commun. 1993; 190(1):125-33. DOI: 10.1006/bbrc.1993.1020. View

17.

Mine N, Iwamoto R, Mekada E . HB-EGF promotes epithelial cell migration in eyelid development. Development. 2005; 132(19):4317-26. DOI: 10.1242/dev.02030. View

18.

Takemura T, Hino S, Kuwajima H, Yanagida H, Okada M, Nagata M . Induction of collecting duct morphogenesis in vitro by heparin-binding epidermal growth factor-like growth factor. J Am Soc Nephrol. 2001; 12(5):964-972. DOI: 10.1681/ASN.V125964. View

19.

Kirkland G, Paizis K, Wu L, Katerelos M, Power D . Heparin-binding EGF-like growth factor mRNA is upregulated in the peri-infarct region of the remnant kidney model: in vitro evidence suggests a regulatory role in myofibroblast transformation. J Am Soc Nephrol. 1998; 9(8):1464-73. DOI: 10.1681/ASN.V981464. View

20.

Taniyama Y, Morishita R, Aoki M, Hiraoka K, Yamasaki K, Hashiya N . Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension. 2002; 40(1):47-53. DOI: 10.1161/01.hyp.0000020755.56955.bf. View